UnknownNot Applicable

the Effect of the CALIGALOC Orthosis on Standing and Walking of Hemiparetic Patients With Ankle Varus

France30 participantsStarted 2019-02-22

Plain-language summary

To assess the benefit of an anti-varus ankle foot orthosis (CALIGALOC, Bauerfeind) on gait and balance parameters in hemiparetic patients.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hemiparesis at \> 3 months (whatever the etiology) * varus or equinovarus foot disturbing the stance phase of gait * Able to walk at least 10m, with or without assistive device Exclusion Criteria: * unable to walk 10m * Botulinum toxin injection less than 3 months before inclusion * history of neurological or locomotor pathology in addition to the etiology of hemiparesis * Severe comprehension troubles * Pregnancy

What they're measuring

10-meter walk test (in seconds)

Timeframe: comparison between baseline and 15 days

Trial details

NCT IDNCT03668561

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12

Contact for this trial

Etienne Allart, MD

3 20 44 48 71 etienne.allart@chru-lille.fr

View on ClinicalTrials.gov More Hemiparesis trials